Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127921) titled 'Effects of Remimazolam and Dexmedetomidine on Sleep Quality in Postoperative Maxillofacial Surgery Patients in the ICU' on July 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Huashan Hospital Affiliated to Fudan University
Condition:
Sleep disorder
Intervention:
Group B:Dexmedetomidine at a dose of 0.2 to 0.7µg/kg/h was continuously intravenously pumped from 22:00 on the day of the operation to 06:00 the next day.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-15
Target Sample Size: Group B:63;Group A:63;
Countries of Recruitment:...